α-Fetoprotein, Des-γ Carboxyprothrombin, and Lectin-Bound α-Fetoprotein in Early Hepatocellular Carcinoma

Gastroenterology

Volumn 137, Issue 1, 2009, Pages 110-118

  Marrero, Jorge A ^a   Feng, Ziding ^b   Wang, Yinghui ^b   Nguyen, Mindie H ^c   Befeler, Alex S ^d   Roberts, Lewis R ^e   Reddy, K Rajender ^f   Harnois, Denise ^g   Llovet, Josep M ^h,i   Normolle, Daniel ^a   Dalhgren, Jackie ^b   Chia, David ^j   Lok, Anna S ^a   Wagner, Paul D ^k   Srivastava, Sudhir ^j   Schwartz, Myron ^h  

^a UNIVERSITY OF MICHIGAN   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c STANFORD UNIVERSITY   (United States)

^d SAINT LOUIS UNIVERSITY   (United States)

^e MAYO CLINIC   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g MAYO CLINIC   (United States)

^h Mt Sinai Liver Cancer Program   (United States)

ⁱ INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k NATIONAL CANCER INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; DECARBOXYPROTHROMBIN; LECTIN BOUND ALPHA FETOPROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER DIAGNOSIS; CASE CONTROL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EARLY CANCER; EARLY DIAGNOSIS; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SINGLE BLIND PROCEDURE; UNITED STATES;

EID: 67649305155     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2009.04.005     Document Type: Article

References (25)

1. Ferlay J., Bray F., Pisani P., et al. GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. IARC CancerBase No. 5. version 2.0 (2004), IARC Press, Lyon
2. El-Serag H.B. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology 127 (2004) S27-S34
3. Parkin D.M. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 118 (2006) 3030-3044
4. Bruix J., and Sherman M. Management of hepatocellular carcinoma. Hepatology 42 (2005) 1208-1236
5. El-Serag H.B., and Mason A.C. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 340 (1999) 745-750
6. El-Serag H.B., Marrero J.A., Rudolph L., et al. Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology 134 (2008) 1752-1763
7. Fattovich G., Stroffolini T., Zagni I., et al. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 127 (2004) S35-S50
8. Marrero J.A., Hussain H.K., Nghiem H.V., et al. Improving the prediction of hepatocellular carcinoma in cirrhotic patients with an arterially-enhancing liver mass. Liver Transpl 11 (2005) 281-289
9. Pepe M.S., Etzioni R., Feng Z., et al. Phases of biomarker development for early detection of cancer. J Natl Cancer Inst 93 (2001) 1054-1061
10. Colli A., Fraquelli M., and Conte D. Alpha-fetoprotein and hepatocellular carcinoma. Am J Gastroenterol 101 (2006) 1939-1941
11. Gupta S., Bent S., and Kohlwes J. Test characteristics of α-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis. Ann Intern Med 139 (2003) 46-50
12. Gebo K.A., Chander G., Jenckes M.W., et al. Screening tests for hepatocellular carcinoma in patients with chronic hepatitis C: a systematic review. Hepatology 36 (2002) S84-S92
13. Ono M., Ohta H., Ohhira M., et al. Measurement of immunoreactive prothrombin precursor and vitamin-K-dependent γ-carboxylation in human hepatocellular carcinoma tissues: decreased carboxylation of prothrombin precursor as a cause of des-γ-carboxyprothrombin synthesis. Tumour Biol 11 (1990) 319-326
14. Shimauchi Y., Tanaka M., Kuromatsu R., et al. A simultaneous monitoring of Lens culinaris agglutinin A-reactive α-fetoprotein and des-γ-carboxy prothrombin as an early diagnosis of hepatocellular carcinoma in the follow-up of cirrhotic patients. Oncol Rep 7 (2000) 249-256
15. Marrero J.A., Su G.L., Wei W., et al. Des-γ carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in American patients. Hepatology 37 (2003) 1114-1121
16. Ikoma J., Kaito M., Ishihara T., et al. Early diagnosis of hepatocellular carcinoma using a sensitive assay for serum des-γ-carboxy prothrombin: a prospective study. Hepatogastroenterology 49 (2002) 235-238
17. Ishii M., Gama H., Chida N., et al., South Tohoku District Study Group. Simultaneous measurements of serum α-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. Am J Gastroenterol 95 (2000) 1036-1040
18. Sato Y., Nakata K., Kato Y., et al. Early recognition of hepatocellular carcinoma based on altered profiles of α-fetoprotein. N Engl J Med 328 (1993) 1802-1806
19. Shiraki K., Takase K., Tameda Y., et al. A clinical study of lectin-reactive α-fetoprotein as an early indicator of hepatocellular carcinoma in the follow-up of cirrhotic patients. Hepatology 22 (1995) 802-807
20. Wang S.S., Lu R.H., Lee F.Y., et al. Utility of lentil lectin affinity of α-fetoprotein in the diagnosis of hepatocellular carcinoma. J Hepatol 25 (1996) 166-171
21. Sterling R.K., Jeffers L., Gordon F., et al. Clinical utility of AFP-L3% measurement in North American patients with HCV-related cirrhosis. Am J Gastroenterol 102 (2007) 2196-2205
22. Bruix J., Sherman M., Llovet J.M., et al., European Association for the Study of the Liver. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. J Hepatol 35 (2001) 421-430
23. Trevisani F., D'Intino P.E., Morselli-Labate A.M., et al. Serum α-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status. J Hepatol 34 (2001) 570-575
24. Marrero J.A. Screening tests for hepatocellular carcinoma. Clin Liver Dis 9 (2005) 235-251
25. Volk M.L., and Marrero J.A. Early detection of liver cancer: diagnosis and management. Curr Gastroenterol Rep 10 (2008) 60-66